Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause
ConditionInsulin Resistance Syndrome
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexFemale
Age55-65
SponsorCairo University
About this trial
Background: In postmenopausal females, Insulin resistance is commonly encountered in clinical setting. Hyperbaric oxygen therapy have been proposed effective in lowering blood glucose level and improving function. Identification of clinical examination variables as predictors to blood glucose levels and dysfunction would offer therapists the chance to undertake clinical decisions and consequently improve treatment efficiency.
Objectives: This Predictive validity, diagnostic study conduct to examine the effect of hyperbaric oxygen therapy on insulin resistance in postmenopausal women.
Eligibility criteria
Qualifiers
A)Inclusion Criteria
All females were clinically diagnosed with Postmenopausal Insulin resistance.
Their ages were ranged from 55-65 years old.
Their BMI was 30-34.9 kg/m².
Disqualifiers
Chronic obstructive pulmonary disease.
Cardiac pacemakers.
Epileptic fits.
Physically disable .
Trial design
Treatments tested in this trial
- Hyperbaric oxygen therapy
- Hypoglycemic Drug
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov